Urogenital side effects in male subjects with type 2 diabetes treated with SGLT-2 inhibitors: A single centre, longitudinal observation

SGLT-2 inhibitors (SGLT-2i) provide good glycaemic control and weight loss, ensuring clinically relevant cardiorenal benefits in subjects with and without type 2 diabetes (T2D); however, their use is related to an enhanced risk of urogenital infections, mainly in female subjects. We performed a pros...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of diabetes and its complications Vol. 39; no. 5; p. 109015
Main Authors:	Del Zoppo, Alice, Rovera, Chiara, Petralli, Giovanni, Moriconi, Diego, Solini, Anna
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01.05.2025 Elsevier Limited
Subjects:	Aged Biochemistry BMI Clinical trials Compliance Creatinine Diabetes Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - epidemiology DPP-IV inhibitors Fasting Females Genotype & phenotype Glucose Heart failure Hospitals Humans Incidence Infections Laboratories Longitudinal Studies Male Male Urogenital Diseases - chemically induced Male Urogenital Diseases - epidemiology Metabolism Middle Aged Prospective Studies SGLT-2 inhibitors Side effects Sodium-Glucose Transporter 2 Inhibitors - adverse effects Sodium-Glucose Transporter 2 Inhibitors - therapeutic use Urogenital complications DPP-IV inhibitors SGLT-2 inhibitors Compliance Urogenital complications BMI
ISSN:	1056-8727, 1873-460X, 1873-460X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!